Alpha-synuclein research: defining strategic moves in the battle against Parkinson’s disease

Alpha-synuclein research: defining strategic moves in the battle against Parkinson’s disease

Abstract With the advent of the genetic era in Parkinson’s disease (PD) research in 1997, α-synuclein was identified as an important player in a complex neurodegenerative disease that affects >10 million people worldwide. PD has been estimated to have an economic impact of $51.9 billion in the US...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Luis M. A. Oliveira, Thomas Gasser, Robert Edwards, Markus Zweckstetter, Ronald Melki, Leonidas Stefanis, Hilal A. Lashuel, David Sulzer, Kostas Vekrellis, Glenda M. Halliday, Julianna J. Tomlinson, Michael Schlossmacher, Poul Henning Jensen, Julia Schulze-Hentrich, Olaf Riess, Warren D. Hirst, Omar El-Agnaf, Brit Mollenhauer, Peter Lansbury, Tiago F. Outeiro
Format: article
Langue:EN
Publié: Nature Portfolio 2021
Sujets:
Neurology. Diseases of the nervous system
RC346-429
Accès en ligne:https://doaj.org/article/78fcd2512d1c4506897e5895f2a201f4
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/78fcd2512d1c4506897e5895f2a201f4

Documents similaires